ENTRY       D10823                      Drug
NAME        Clopidogrel hydrochloride;
            Clopidogrel (TN)
FORMULA     C16H16ClNO2S. HCl
EXACT_MASS  357.0357
MOL_WEIGHT  358.2827
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
               DG01808  Thienopyridine
             DG01809  P2Y12 receptor antagonist
              DG01808  Thienopyridine
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG02919  CYP2B6 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01641  CYP2C8 inhibitor
REMARK      ATC code: B01AC04
            Chemical structure group: DG00155
            Product (DG00155): D00769<JP/US>
EFFICACY    Anticoagulant, Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist
COMMENT     Thienopyridine derivative
TARGET      P2RY12 [HSA:64805] [KO:K04298]
  PATHWAY   hsa04611(64805)  Platelet activation
METABOLISM  Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]
INTERACTION CYP inhibition: CYP2C8 [HSA:1558]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC04 Clopidogrel
                  D10823  Clopidogrel hydrochloride
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01808  Thienopyridine
                 DG00155  Clopidogrel
                  D10823  Clopidogrel hydrochloride
              DG01809  P2Y12 receptor antagonist
               DG01808  Thienopyridine
                DG00155  Clopidogrel
                 D10823  Clopidogrel hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00155  Clopidogrel
                D10823  Clopidogrel hydrochloride
              DG02919  CYP2B6 substrate
               DG00155  Clopidogrel
                D10823  Clopidogrel hydrochloride
              DG01639  CYP2C19 substrate
               DG00155  Clopidogrel
                D10823  Clopidogrel hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00155  Clopidogrel
                 D10823  Clopidogrel hydrochloride
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               DG00155  Clopidogrel
                D10823  Clopidogrel hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Purine / pyrimidine
                P2RY12
                 D10823  Clopidogrel hydrochloride
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10823
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10823
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01808  Thienopyridine
                 DG00155  Clopidogrel
              DG01809  P2Y12 receptor antagonist
               DG01808  Thienopyridine
                DG00155  Clopidogrel
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00155  Clopidogrel
              DG02919  CYP2B6 substrate
               DG00155  Clopidogrel
              DG01639  CYP2C19 substrate
               DG00155  Clopidogrel
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00155  Clopidogrel
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               DG00155  Clopidogrel
DBLINKS     CAS: 120202-65-5
            PubChem: 319902623
ATOM        22
            1   N1y N    18.7472  -15.8092
            2   C1c C    17.5580  -16.5087
            3   C1x C    19.9364  -16.5087
            4   C1x C    18.7472  -14.4102
            5   C8y C    16.3688  -15.8092
            6   C7a C    17.5580  -17.9078
            7   C8y C    21.1955  -15.8092
            8   C1x C    19.9364  -13.7106
            9   C8y C    16.3688  -14.4102
            10  C8x C    15.1097  -16.5087
            11  O7a O    16.3688  -18.6073
            12  O6a O    18.7472  -18.6073
            13  C8y C    21.1955  -14.4102
            14  C8x C    22.5246  -16.2289
            15  C8x C    15.1097  -13.7106
            16  X   Cl   17.5580  -13.7106
            17  C8x C    13.9205  -15.8092
            18  C1a C    15.1097  -17.9078
            19  S2x S    22.5246  -13.9905
            20  C8x C    23.3641  -15.1097
            21  C8x C    13.9205  -14.4102
            22  X   Cl   22.9600  -18.7600
BOND        23
            1     2   5 1
            2     2   6 1 #Down
            3     3   7 1
            4     4   8 1
            5     5   9 1
            6     5  10 2
            7     6  11 1
            8     6  12 2
            9     7  13 2
            10    7  14 1
            11    9  15 2
            12    9  16 1
            13   10  17 1
            14   11  18 1
            15   13  19 1
            16   14  20 2
            17   15  21 1
            18    8  13 1
            19   17  21 2
            20   19  20 1
            21    1   2 1
            22    1   3 1
            23    1   4 1
///
